Chularat Hospital 将来の成長

Future 基準チェック /26

Chularat Hospital利益と収益がそれぞれ年間10.3%と7.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に16.4% 8%なると予測されています。

主要情報

10.3%

収益成長率

8.0%

EPS成長率

Healthcare 収益成長	10.4%
収益成長率	7.2%
将来の株主資本利益率	16.4%
アナリストカバレッジ	Good
最終更新日	25 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

SET:CHG - アナリストの将来予測と過去の財務データ ( )THB Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	10,101	1,407	1,240	1,890	8
12/31/2025	9,381	1,299	1,169	1,729	10
12/31/2024	8,460	1,121	916	1,649	6
9/30/2024	8,733	1,147	1,188	1,841	N/A
6/30/2024	8,520	1,056	932	1,841	N/A
3/31/2024	8,332	1,070	755	1,809	N/A
12/31/2023	8,014	1,046	952	2,087	N/A
9/30/2023	7,643	1,058	1,772	3,028	N/A
6/30/2023	7,574	990	1,880	2,951	N/A
3/31/2023	8,558	1,662	1,056	1,930	N/A
12/31/2022	10,408	2,778	1,806	2,629	N/A
9/30/2022	12,526	4,306	3,525	4,226	N/A
6/30/2022	14,883	5,611	3,167	3,779	N/A
3/31/2022	14,166	5,309	4,401	5,015	N/A
12/31/2021	11,999	4,204	3,522	4,005	N/A
9/30/2021	9,589	2,645	1,254	1,615	N/A
6/30/2021	6,598	1,363	1,423	1,721	N/A
3/31/2021	5,612	942	1,243	1,498	N/A
12/31/2020	5,462	877	1,004	1,298	N/A
9/30/2020	5,270	757	627	1,092	N/A
6/30/2020	5,241	744	518	1,122	N/A
3/31/2020	5,277	712	391	1,026	N/A
12/31/2019	5,188	705	241	974	N/A
9/30/2019	4,998	683	122	735	N/A
6/30/2019	4,715	565	119	715	N/A
3/31/2019	4,575	620	14	705	N/A
12/31/2018	4,427	634	45	695	N/A
9/30/2018	4,305	648	167	862	N/A
6/30/2018	4,187	665	N/A	952	N/A
3/31/2018	4,038	606	N/A	925	N/A
12/31/2017	3,894	565	N/A	910	N/A
9/30/2017	3,790	571	N/A	849	N/A
6/30/2017	3,721	563	N/A	805	N/A
3/31/2017	3,705	560	N/A	660	N/A
12/31/2016	3,655	564	N/A	705	N/A
9/30/2016	3,595	575	N/A	860	N/A
6/30/2016	3,436	536	N/A	704	N/A
3/31/2016	3,326	562	N/A	785	N/A
12/31/2015	3,171	538	N/A	698	N/A
9/30/2015	3,020	508	N/A	444	N/A
6/30/2015	2,904	514	N/A	555	N/A
3/31/2015	2,783	490	N/A	515	N/A
12/31/2014	2,695	481	N/A	446	N/A
9/30/2014	2,580	476	N/A	486	N/A
6/30/2014	2,497	475	N/A	368	N/A
3/31/2014	2,374	448	N/A	285	N/A
12/31/2013	2,234	414	N/A	309	N/A

アナリストによる今後の成長予測

収入対貯蓄率: CHGの予測収益成長率 (年間10.3% ) は貯蓄率 ( 2% ) を上回っています。

収益対市場: CHGの収益 ( 10.3% ) TH市場 ( 17.6% ) よりも低い成長が予測されています。

高成長収益: CHGの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: CHGの収益 ( 7.2% ) TH市場 ( 6.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: CHGの収益 ( 7.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: CHGの自己資本利益率は、3年後には低くなると予測されています ( 16.4 %)。

Chularat Hospital 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Price target decreased by 7.2% to ฿3.85

Consensus EPS estimates increase by 18%

Consensus EPS estimates increase by 27%

Consensus forecasts updated

Recent updates

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Now 21% overvalued after recent price rise

First half dividend of ฿0.02 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2024 to 30 June 2024, Payable on September 13, 2024

First quarter 2024 earnings released: EPS: ฿0.024 (vs ฿0.022 in 1Q 2023)

Now 22% overvalued

Now 21% overvalued

Now 21% overvalued

Final dividend of ฿0.05 announced

Full year 2023 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Third quarter 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chularat Hospital Public Company Limited Approves an Interim Dividend for the Six-Month Period Ended 30 June 2023, Payable on 8 September 2023

Price target decreased by 7.2% to ฿3.85

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ฿0.075 per share at 4.4% yield

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Upcoming dividend of ฿0.085 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2022 to 30 June 2022, Payable on September 9, 2022

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Consensus EPS estimates increase by 18%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ฿0.17 per share

Less than half of directors are independent

Consensus EPS estimates increase by 27%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Chularat Hospital Public Company Limited Proposes Interim Dividend, Payable on or Before May 20, 2022

Third quarter 2021 earnings released: EPS ฿0.14 (vs ฿0.026 in 3Q 2020)

Upcoming dividend of ฿0.03 per share

Consensus forecasts updated

Price target increased to ฿4.27

Chularat Hospital Public Company Limited (SET:CHG) acquired additional 10% stake in Ruampat Mae Sot International Company.

Consensus EPS estimates increase to ฿0.10

First quarter 2021 earnings released: EPS ฿0.023 (vs ฿0.017 in 1Q 2020)

Upcoming dividend of ฿0.03 per share

New 90-day high: ฿2.78

Full year 2020 earnings released: EPS ฿0.08 (vs ฿0.064 in FY 2019)

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 23, 2021

New 90-day high: ฿2.74

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ฿0.026

Upcoming Dividend of ฿0.02 Per Share

First half earnings released

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘